ArticleJournal of clinical medicine2023

Dinutuximab Beta Maintenance Therapy in Patients with High-Risk Neuroblastoma in First-Line and Refractory/Relapsed Settings-Real-World Data.

Aleksandra Wieczorek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.